Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer

Sen F., Saglam E. K., Toker A., Dilege S., Kizir A., Oral E. N., ...More

CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.68, no.6, pp.1497-1505, 2011 (SCI-Expanded) identifier identifier identifier


The aim of this study was to evaluate efficacy and feasibility of a combination of weekly docetaxel and cisplatin administered concomitantly with radiotherapy followed by surgery in addition to consolidation chemotherapy with docetaxel and cisplatin administered every 3 weeks in stage III non-small cell lung cancer (NSCLC).